Related Experiment Videos
Restenosis after coronary stenting in current clinical practice
D Antoniucci1, R Valenti, G M Santoro
1Division of Cardiology, Careggi Hospital, Florence, Italy.
American Heart Journal
|March 20, 1998
Summary
Coronary stenting in complex lesions, not typically studied in trials, shows a 23% restenosis rate. Factors like older age, female sex, longer lesions, and complex lesion types increase restenosis risk.
Area of Science:
- Cardiovascular medicine
- Interventional cardiology
- Medical device research
Background:
- Randomized trials suggest coronary stenting benefits for short, simple lesions.
- Real-world practice involves complex lesions often excluded from trials.
- This study evaluates stenting outcomes in unselected patients with diverse lesion types.
Purpose of the Study:
- To assess restenosis, reocclusion, and adverse events after coronary stenting in consecutive, nonselected patients.
- To identify factors associated with restenosis in a broad patient population.
- To compare outcomes of stenting in complex versus simple coronary lesions.
Main Methods:
- Prospective study of 258 patients undergoing coronary stenting.
- Inclusion criteria allowed for complex lesions (dissection, high stenosis, restenotic, chronic total occlusion).
- Multivariate analysis identified independent predictors of restenosis.
Main Results:
- Most target lesions (89%) had complex morphologic characteristics.
- The overall 6-month restenosis rate was 23%, with subgroup rates varying from 11% to 46%.
- Independent predictors of restenosis included age > 63 years, female sex, lesion length > 12 mm, and type C lesion.
Conclusions:
- Findings from randomized trials may not apply to current clinical practice due to lesion complexity.
- Restenosis rates are significantly higher for long and complex lesions treated with multiple stents.
- Further research is needed to establish the efficacy of stenting for complex coronary lesions.